OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications
Fig 8
The open-world problem in pharmacovigilance.
The numbers extractable from any adverse event database (DE, dE, De, de) come from a subset, i.e., all the reported cases. The rest of the population is unknown to the system.